Insight Molecular Diagnostics Basic EPS 2014-2025 | IMDX
Insight Molecular Diagnostics basic eps from 2014 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Insight Molecular Diagnostics Annual Basic EPS | |
|---|---|
| 2024 | $-4.66 |
| 2023 | $-3.75 |
| 2022 | $-13.25 |
| 2021 | $-14.40 |
| 2020 | $-9.20 |
| 2019 | $-8.80 |
| 2018 | $-8.40 |
| 2017 | $-12.80 |
| 2016 | $-8.40 |
| 2015 | $-8.40 |
| 2014 | $-5.40 |
| 2013 | $-3.80 |
| Insight Molecular Diagnostics Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $-0.26 |
| 2024-12-31 | $-2.19 |
| 2024-09-30 | $-0.98 |
| 2024-06-30 | $-0.36 |
| 2024-03-31 | $-1.13 |
| 2023-12-31 | $-2.27 |
| 2023-09-30 | $-0.81 |
| 2023-06-30 | $-1.07 |
| 2023-03-31 | $0.40 |
| 2022-12-31 | $-7.95 |
| 2022-09-30 | $-1.62 |
| 2022-06-30 | $-1.48 |
| 2022-03-31 | $-2.20 |
| 2021-12-31 | $-8.00 |
| 2021-09-30 | $-3.00 |
| 2021-06-30 | $-2.40 |
| 2021-03-31 | $-1.00 |
| 2020-12-31 | $-1.80 |
| 2020-09-30 | $-2.00 |
| 2020-06-30 | $-2.80 |
| 2020-03-31 | $-2.60 |
| 2019-12-31 | $-3.20 |
| 2019-09-30 | $-2.00 |
| 2019-06-30 | $-2.00 |
| 2019-03-31 | $-1.60 |
| 2018-12-31 | $-2.20 |
| 2018-09-30 | $-1.40 |
| 2018-06-30 | $-2.40 |
| 2018-03-31 | $-2.40 |
| 2017-12-31 | $-2.60 |
| 2017-09-30 | $-4.40 |
| 2017-06-30 | $-2.60 |
| 2017-03-31 | $-3.20 |
| 2016-12-31 | $-2.00 |
| 2016-09-30 | $-2.00 |
| 2016-06-30 | $-2.00 |
| 2016-03-31 | $-2.40 |
| 2015-12-31 | $-2.80 |
| 2015-09-30 | $-2.40 |
| 2015-06-30 | $-1.40 |
| 2015-03-31 | $-1.60 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.073B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.976B | 58.49 |
| Hims & Hers Health (HIMS) | United States | $14.001B | 145.46 |
| Doximity (DOCS) | United States | $10.768B | 49.85 |
| Tempus AI (TEM) | United States | $9.502B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.300B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.719B | 58.11 |
| Hinge Health (HNGE) | United States | $3.507B | 0.00 |
| Privia Health (PRVA) | United States | $2.299B | 157.17 |
| 10x Genomics (TXG) | United States | $1.611B | 0.00 |
| Phreesia (PHR) | United States | $1.567B | 0.00 |
| Azenta (AZTA) | United States | $1.481B | 68.81 |
| Enovis (ENOV) | United States | $1.470B | 8.20 |
| Schrodinger (SDGR) | United States | $1.433B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.415B | 0.00 |
| Omnicell (OMCL) | United States | $1.394B | 26.34 |
| Evolent Health (EVH) | United States | $1.172B | 99.80 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.564B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.387B | 115.50 |
| Carlsmed (CARL) | $0.361B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 684.67 |
| Outset Medical (OM) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.249B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.245B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| CapsoVision (CV) | United States | $0.181B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |